Trials / Sponsors / Promontory Therapeutics Inc.
Promontory Therapeutics Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab Non-Small Cell Lung Cancer (NSCLC) | Phase 1 / Phase 2 | 2018-04-24 |
| Completed | A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 1 | 2017-12-15 |
| Active Not Recruiting | A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Inj Advanced Solid Tumors, CRPC, mCRPC | Phase 2 | 2014-07-01 |